NASDAQ · MEDS
Healthcare · Medical - Pharmaceuticals
$1.33
Up+$0.11 (+8.45%)
Updated Aug 13, 2026, 6:33 PM
SID Score
—
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 16 trading sessions · Daily adjusted prices
MEDS closed at $1.33 after 16 trading sessions, down 62.85% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 12, 2026 | $1.42 | $1.42 | $1.28 | $1.33 | 107.62K |
| Aug 11, 2026 | $1.63 | $1.6385 | $1.3172 | $1.39 | 816.33K |
| Aug 10, 2026 | $2.02 | $2.09 | $1.60 | $1.60 | 164.02K |
| Aug 7, 2026 | $2.68 | $2.7775 | $1.90 | $1.99 | 196.39K |
| Aug 6, 2026 | $2.82 | $3.18 | $2.63 | $2.64 | 148.44K |
| Aug 5, 2026 | $3.27 | $3.74 | $2.79 | $2.80 | 602.91K |
| Aug 4, 2026 | $3.23 | $3.25 | $3.06 | $3.17 | 24.39K |
| Aug 3, 2026 | $3.14 | $3.30 | $3.02 | $3.24 | 27.28K |
| Jul 31, 2026 | $3.25 | $3.275 | $3.00 | $3.02 | 47.35K |
| Jul 30, 2026 | $3.16 | $3.245 | $3.12 | $3.16 | 38.29K |
| Jul 29, 2026 | $3.57 | $3.87 | $2.97 | $3.00 | 79.93K |
| Jul 28, 2026 | $3.18 | $3.88 | $3.04 | $3.55 | 91.89K |
| Jul 27, 2026 | $3.15 | $3.15 | $2.862 | $3.12 | 7.66K |
| Jul 24, 2026 | $3.245 | $3.31 | $3.05 | $3.17 | 22.64K |
| Jul 23, 2026 | $3.32 | $3.33 | $2.97 | $3.28 | 33.82K |
| Jul 22, 2026 | $3.40 | $3.75 | $3.20 | $3.58 | 69.74K |
The latest Smart Investors Daily articles mentioning MEDS.
MEDS research
Company profile and research snapshot.
TRxADE HEALTH, Inc. operates as a health services IT company in the United States. The company focuses on digitalizing the retail pharmacy experience by optimizing drug procurement, prescription journey, and patient engagement. It operates the TRxADE drug procurement marketplace, which fosters price transparency and serves approximately 11,800 members; and offers patient centric telehealth services under the Bonum Health brand name. The company was formerly known as Trxade Group, Inc. and changed its name to TRxADE HEALTH, Inc. in June 2021. TRxADE HEALTH, Inc. is based in Land O' Lakes, Florida.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| May 16, 2023 | EF Hutton | Buy | — |
| Mar 28, 2023 | Maxim Group | Buy | — |
| Dec 9, 2021 | EF Hutton | Buy | — |
| Dec 3, 2020 | National Securities | Buy | — |
No generated briefing is available yet.
Benzinga · Jul 31, 2026
Tollovid and Galactovid are marketed by Tollo Health, LLC ("Tollo Health"), a healthcare company focused on the commercialization of nutraceuticals that address specific mechanisms of action and health IT
GlobeNewswire Inc. · Sep 20, 2024
TRxADE Health, Inc. is changing its name to Scienture Holdings, Inc. and its stock will trade under the new ticker symbol SCNX. Scienture, LLC, a wholly-owned subsidiary, is a branded specialty pharmaceutical company that recently merged with TRxADE Health.
GlobeNewswire Inc. · May 29, 2024
TAMPA, FL, May 29, 2024 (GLOBE NEWSWIRE) -- TRxADE HEALTH, Inc. (Nasdaq: MEDS) (the “Company”), announced that, on May 23, 2024, the Company received a notice (the “Notice”) from the Nasdaq Listing Qualifications Department (“Nasdaq”) indicating that because the Company had not yet filed its Quarterly Report on Form 10-Q for the period ending March 31, 2024 (the “Form 10-Q”), the Company is not compliant with the timely filing requirement for continued listing under Nasdaq Listing Rule 5250(c)(1) (the “Listing Rule”), which requires listed companies to timely file all required periodic reports with the Securities and Exchange Commission.
GlobeNewswire Inc. · Mar 6, 2024
TAMPA, FL, March 06, 2024 (GLOBE NEWSWIRE) -- TRxADE HEALTH Inc. (Nasdaq: MEDS) (the “Company”), announced that the Company’s board of directors has declared a special cash dividend of $8.00 per share of common stock. The special dividend is being paid using a portion of the proceeds from the closing of the recently announced sale of the Company’s web-based market platform assets. The special cash dividend is payable to stockholders of record as of March 18, 2024, with the dividend being paid on or about March 22, 2024.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning MEDS.
No results
No recent SID articles mention MEDS.
